Skip to main content

Table 2 Types of vaccines and examples

From: Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases

Carbohydrate/polysaccharide antigens Protein antigen: recombinant/inactivated/conjugated** Live/attenuated organisms
Pneumococcal polysaccharide (PPSV-23, for example, Pneumovax®) Tetanus, diphtheria, acellular pertussis (TD/DT, TDAP, DTAP) Varicella (VZV, Varivax®, Varilrix®)
Meningococcal polysaccharide (MPSV-4) Hepatitis A, hepatitis B Shingles, zoster (for example, Zostavax®)
Typhoid polysaccharide (Vi injection) Seasonal influenza A/B injection Intranasal influenza (for example, Flu-mist®)
Pandemic influenza (H1N1) injection  
Human papilloma virus Measles, mumps, rubella
Anthrax (acellular) Yellow fever
Inactivated polio (IPV, Salk, IM/SQ) Oral polio (OPV)
Oral cholera (killed cells) Typhoid (Ty21a oral)
Pneumococcal conjugate** (PCV-7, PCV-13, for example, Prevnar®) Vaccinia (smallpox)
Meningococcal conjugate** (MCV-4, <55 years old) Bacillus Calmette-Guérin
Haemophilus influenza type B protein polysaccharide conjugate** (HiB, PRP) Rotavirus
Anthrax (live spore)